J2Kbio Co., Ltd. (420570) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for J2Kbio Co., Ltd. (420570:KRX), powered by AI.

Current Price
₩9,390
P/E Ratio
20.5
Market Cap
54.9B
Sector
Basic Materials
What is the J2Kbio Co., Ltd. stock price forecast?

J2Kbio Co., Ltd. is currently trading at ₩9,390. View real-time AI analysis on Alpha Lenz.

What is J2Kbio Co., Ltd. insider trading activity?

View the latest insider trading data for J2Kbio Co., Ltd. on Alpha Lenz.

What is J2Kbio Co., Ltd.'s P/E ratio?

J2Kbio Co., Ltd.'s P/E ratio is 20.5.

J2Kbio Co., Ltd.

KRX · 420570
₩9,390+1,530(+19.47%)Market closedKRX regular session 09:00–15:30 KST
Ask about J2Kbio Co., Ltd.'s future dividend policy...
Alpha Chat Insight

J2Kbio Co., Ltd. trades at a P/E of 20.5 (fair value) with solid ROE of 8.2%. 3Y revenue CAGR of 27.2% highlights clear growth momentum.

Ask for details

Company Overview

J2Kbio Co., Ltd. is a biotechnology company that specializes in the development and manufacturing of biological products. Its primary focus is on leveraging advanced biotechnological processes to create innovative solutions within the healthcare and life sciences industries. The company's product range often includes medical devices, diagnostic tools, and therapeutic biologics, all aimed at improving health outcomes and providing sustainable medical solutions. J2Kbio Co., Ltd. engages in extensive research and development activities, typically collaborating with academic institutions and industry partners to stay at the forefront of biotechnological advancements. Through this approach, it contributes significantly to the progress of personalized medicine and precision healthcare. Positioned within the dynamic and rapidly growing biotech sector, J2Kbio Co., Ltd. plays a crucial role in addressing unmet medical needs and enhancing the quality of life for patients globally. Its emphasis on innovation underscores its importance in the market as a key player driving forward the capabilities and applications of biotechnology.

CEO이재섭
SectorBasic Materials
IndustrySpecialty Chemicals
Employees56

Company Statistics

FY 2025

Profile

₩54,907,865,370Market Cap
₩32,966,351,930Revenue
5.85MShares Out
56Employees

Margins

39.37%Gross
14.04%EBITDA
8.86%Operating
9.23%Pre-Tax
8.11%Net

Valuation

20.54P/E
1.63P/B
1.67EV/Sales
9.46EV/EBITDA
58.17P/FCF

Growth (CAGR)

27.16%Rev 3Yr
18.93%Rev 5Yr
7.91%Op Inc 3Yr
20.99%Op Inc 5Yr
8.99%Net Inc 3Yr
12.62%Net Inc 5Yr

Returns

7.22%ROA
8.21%ROE
8.35%ROIC

Financial Health

₩12,265,203,020Cash & Cash Equivalents
₩-7,972,609,790Net Debt
12.71%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

J2Kbio Co., Ltd. (ticker: 420570) is a company listed on KRX in the Basic Materials sector (Specialty Chemicals). It has approximately 56 employees. Market cap is $54.9B.

The current price is ₩9,390 with a P/E ratio of 20.54x and P/B of 1.63x.

ROE is 8.21% and operating margin is 8.86%. Annual revenue is $33.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
J2Kbio Co., Ltd. (420570) Stock Forecast 2026 ₩9,390 — Price, Financials & Analyst Targets | Alpha Lenz